PARAGON CARE LIMITED (PGC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

PGC - PARAGON CARE LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 3.33
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.19

01 Dec
2023

0.000

OPEN

$0.19

0.000

HIGH

$0.20

321,432

LOW

$0.19

TARGET
$0.26 36.8% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . HLA . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PME . RMD . SOM . TRJ . UBI . VHT . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS
PGC: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx 1.6 2.2 xxx
DPS (cps) xxx 1.2 1.3 xxx
EPS Growth xxx 12.3% 34.1% xxx
DPS Growth xxx 0.0% 8.3% xxx
PE Ratio xxx N/A 8.6 xxx
Dividend Yield xxx N/A 6.8% xxx
Div Pay Ratio(%) xxx 73.2% 59.1% xxx

Dividend yield today if purchased 3 years ago: 4.80%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 6.32

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 18/09 - ex-div 0.6c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx1.6
DPS All xxxxxxxxxxxxxxx1.2
Sales/Revenue xxxxxxxxxxxxxxx307.6 M
Book Value Per Share xxxxxxxxxxxxxxx36.8
Net Operating Cash Flow xxxxxxxxxxxxxxx17.7 M
Net Profit Margin xxxxxxxxxxxxxxx4.18 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx5.37 %
Return on Invested Capital xxxxxxxxxxxxxxx3.76 %
Return on Assets xxxxxxxxxxxxxxx2.90 %
Return on Equity xxxxxxxxxxxxxxx5.37 %
Return on Total Capital xxxxxxxxxxxxxxx7.06 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-10.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx22 M
Long Term Debt xxxxxxxxxxxxxxx100 M
Total Debt xxxxxxxxxxxxxxx122 M
Goodwill - Gross xxxxxxxxxxxxxxx326 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx23 M
Price To Book Value xxxxxxxxxxxxxxx0.64

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx21.0 M
Capex % of Sales xxxxxxxxxxxxxxx6.84 %
Cost of Goods Sold xxxxxxxxxxxxxxx256 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx25 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx2 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

31/08/2023

3

Hold

$0.26

36.84%

Paragon Care's FY23 revenues were a small miss against Bell Potter's forecast due mainly to the closure of Lovell Surgical during the year. Revenues grew by 24% year on year with the main driver being the full year impact of acquisitions.

The final dividend was maintained at 0.6cps and the company has re-introduced a DRP. Following year-end the company completed acquisitions for Carestream Japan in addition to acquiring the minority interest in Quantum Health Thailand.

Paragon expects further organic growth in FY24, accelerating in FY25, which is consistent with the broker's expectation. Bell Potter anticipates another strong year of growth across key markets in Asia.

Buy and 26c target retained.

FORECAST
Bell Potter forecasts a full year FY24 dividend of 1.30 cents and EPS of 2.20 cents.
Bell Potter forecasts a full year FY25 dividend of 1.50 cents and EPS of 2.50 cents.
Access Stockbroker Research History >

PGC STOCK CHART

FNArena News on PGC

1
FNArena Corporate Results Monitor – 31-08-2023

Aug 31 2023 - Australia
2
Weekly Ratings, Targets, Forecast Changes – 28-07-23

Jul 31 2023 - Weekly Reports
3
Australian Broker Call *Extra* Edition – Mar 06, 2023

Mar 06 2023 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Sep 21, 2022

Sep 21 2022 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Sep 02, 2022

Sep 02 2022 - Daily Market Reports

Latest Medical Equipment & Devices News

1
Dr Boreham’s Crucible: Pro Medicus

Oct 23 2023 - Australia
2
Dr Boreham’s Crucible: Cyclopharm

Oct 09 2023 - Small Caps
3
Dr Boreham’s Crucible: Painchek

Sep 11 2023 - Small Caps
4
Margins Signal Integral Diagnostics Recovery

Sep 07 2023 - Australia
5
ResMed: Finding A Base?

Aug 15 2023 - Technicals
6
August Turns ResMed Into Nigel NoMates

Aug 09 2023 - Australia
7
Dr Boreham’s Crucible: Lumos Diagnostics

Jun 19 2023 - Small Caps
8
Fisher & Paykel Healthcare: Lower Margin, Higher Spending

May 30 2023 - Australia
9
Dr Boreham’s Crucible: Impedimed

May 08 2023 - Small Caps
10
Treasure Chest: ResMed’s Benevolent Monopoly

May 01 2023 - Treasure Chest